Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells.
about
Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)Fatty acid binding protein 4 deficiency protects against oxygen-induced retinopathy in micePharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF.Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells.Gene expression levels of the insulin-like growth factor family in patients with AMD before and after ranibizumab intravitreal injections.Protective effects of a novel drug RC28-E blocking both VEGF and FGF2 on early diabetic rat retina.
P2860
Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Ranibizumab efficiently blocks ...... in retinal endothelial cells.
@en
Ranibizumab efficiently blocks ...... in retinal endothelial cells.
@nl
type
label
Ranibizumab efficiently blocks ...... in retinal endothelial cells.
@en
Ranibizumab efficiently blocks ...... in retinal endothelial cells.
@nl
prefLabel
Ranibizumab efficiently blocks ...... in retinal endothelial cells.
@en
Ranibizumab efficiently blocks ...... in retinal endothelial cells.
@nl
P2093
P2860
P1476
Ranibizumab efficiently blocks ...... in retinal endothelial cells.
@en
P2093
Gabriele E Lang
Gerhard K Lang
Heidrun L Deissler
Helmut Deissler
P2860
P2888
P304
P356
10.1007/S00417-013-2393-5
P577
2013-06-13T00:00:00Z